News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-23 5:1:34 am SAB Biotherapeutics to Present at the BIO CEO & Investor Conference GlobeNewsWire
2024-02-08 5:0:0 am SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference GlobeNewswire
2024-02-02 4:30:0 am SAB Biotherapeutics Announces Executive Leadership Change GlobeNewswire
2024-01-23 2:58:0 pm SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire
2024-01-05 2:37:3 am Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week Simply Wall St.
2024-01-02 1:30:0 pm SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split GlobeNewswire
2023-11-29 10:29:8 am SAB Biotherapeutics Starts Human Clinical Trial of Diabetes Treatment Exec Edge
2023-11-29 4:30:0 am SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information